• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ MGIT¿ MYCOBACTERIA GROWTH INDICATOR TUBES, 7ML; SYSTEM, BLOOD CULTURING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ MGIT¿ MYCOBACTERIA GROWTH INDICATOR TUBES, 7ML; SYSTEM, BLOOD CULTURING Back to Search Results
Catalog Number 245122
Device Problem Contamination of Device Ingredient or Reagent (2901)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/01/2023
Event Type  malfunction  
Manufacturer Narrative
H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported when using the bd bbl¿ mgit¿ mycobacteria growth indicator tubes, 7ml has contamination and also noted that there was insufficient volume of media.There was no report of impact to patient or user.
 
Event Description
It was reported when using the bd bbl¿ mgit¿ mycobacteria growth indicator tubes, 7ml has contamination and also noted that there was insufficient volume of media.There was no report of impact to patient or user.
 
Manufacturer Narrative
H.6.Investigation summary: material 245122 is manufactured by rehydrating the media components with usp purified water, and thoroughly mixing until a homogeneous solution is obtained.The tubes are filled, capped, torqued and then labeled by machine per standard operating procedure (sop).The tubes are terminally autoclaved in an air over pressure (aop) autoclave, per manufacturing instructions, using a validated cycle.Post autoclaving, tubes are packaged into final shipping configurations.Batch history record review for batch 3110082 was satisfactory per internal procedures.Formulation, filling, torquing, and autoclaving processes were within specifications.The release testing that is performed on this product includes media appearance.In process checks are performed during manufacturing at designated intervals per procedures.Checks for fill volume were complete and within specifications per procedures.As part of the release criteria for this product, the bhr is reviewed to confirm the following: --the total elapsed time between end of formulation and start of the autoclave cycle was within the specified limits.--all autoclave parameters conformed to the validated cycle parameters for this product.--the minimum f0 for this product was met.The complaint history was reviewed, and there is one other complaint for low fill.Retention samples from batch 3110082 (100 tubes) were available for inspection.No contamination, turbidity nor low fill was observed in the retention tubes.For investigation, retention tubes were divided and incubated at 20-25 degrees c (5 tubes) and 30-35 degrees c (5 tubes) and no growth was observed at seven days incubation.There was one photo submitted for investigation of batch 3110082.The photo showed 4 handheld tubes of visible low fill and contamination from batch 3110082.Two of the tubes had black growth in the tube.One of the tubes appeared cloudy.There were no returns submitted for investigation of this complaint.This complaint can be confirmed for low fill and contamination.No complaint trends for this complaint have been identified for this product; no actions are indicated at this time.Bd will continue to trend complaints for fill volume and contamination defects.H3 other text : see h.10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL¿ MGIT¿ MYCOBACTERIA GROWTH INDICATOR TUBES, 7ML
Type of Device
SYSTEM, BLOOD CULTURING
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jo doyka
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key18379805
MDR Text Key331377591
Report Number1119779-2023-01396
Device Sequence Number1
Product Code MDB
UDI-Device Identifier30382902451229
UDI-Public(01)30382902451229
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K974883
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number245122
Device Lot Number3110082
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/02/2023
Initial Date FDA Received12/21/2023
Supplement Dates Manufacturer Received04/18/2024
Supplement Dates FDA Received05/15/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/20/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-